HbE/beta thalassaemia

HbE/beta thalassaemia happens when you inherit a beta thalassaemia gene from one parent and a haemoglobin E gene from the other. It is the most common severe form of thalassaemia across South and Southeast Asia, and it behaves differently from beta thalassaemia major in one important way: it is far less predictable.

Why it varies so much

Haemoglobin E is itself a mild variant. Paired with a beta thalassaemia gene, the result can sit anywhere on a wide range. Some people are barely affected and never need regular transfusions. Others need them from early childhood and are managed exactly like beta thalassaemia major. Many sit somewhere in between and can shift over time.

Two people with the same diagnosis on paper can therefore need genuinely different care. If your experience does not match someone else’s with the same label, that is expected rather than a sign something is wrong.

What that means for transfusions

Because severity varies, the decision to start regular transfusions is made on how you are doing — your haemoglobin, your growth, your spleen, how you feel day to day — rather than on the diagnosis alone. Some people with HbE/beta are managed at a lower pre-transfusion haemoglobin target than beta thalassaemia major, but that is a judgement your team makes for you, not a fixed rule.

Your own targets in MUIY follow the type and treatment you set up, which is why it is worth getting those right.

What still applies

Everything else is familiar. If you are transfused regularly, iron builds up and needs chelation. Even without regular transfusions, iron can accumulate slowly from the gut, so monitoring still matters. Growth, hormones, the spleen and the heart are all watched the same way.

The label matters less than the pattern. What your team follows is your numbers over time.